EMEA (Europe, Middle East and Africa) Oligonucleotide Synthesis Market Report 2018
![](/report_cover/6975/emea-europe-middle-east-n-africa-oligonucleotide-synthesis-market-report-2018_qyresearch_en.gif)
In this report, the EMEA Oligonucleotide Synthesis market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oligonucleotide Synthesis for these regions, from 2013 to 2025 (forecast)
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oligonucleotide Synthesis for these regions, from 2013 to 2025 (forecast)
- Europe: Germany, France, UK, Russia, Italy and Benelux;
- Middle East: Saudi Arabia, Israel, UAE and Iran;
- Africa: South Africa, Nigeria, Egypt and Algeria.
- INTEGRATED DNA TECHNOLOGIES, INC.
- MERCK KGAA
- EUROFINS GENOMICS
- THERMO FISHER SCIENTIFIC INC.
- BIOAUTOMATION CORPORATION
- AGILENT TECHNOLOGIES, INC.
- EUROGENTEC S.A.
- GENERAL ELECTRIC (GE) COMPANY
- LGC BIOSEARCH TECHNOLOGIES, INC.
- NITTO DENKO AVECIA INC.
- Primer
- Probe
- Reagent
- Academic
- Pharmaceutical
- Biotechnology
EMEA (Europe, Middle East and Africa) Oligonucleotide Synthesis Market Report 2018
1 OLIGONUCLEOTIDE SYNTHESIS OVERVIEW
1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Classification of Oligonucleotide Synthesis
1.2.1 EMEA Oligonucleotide Synthesis Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Oligonucleotide Synthesis Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Primer
1.2.4 Probe
1.2.5 Reagent
1.3 EMEA Oligonucleotide Synthesis Market by Application/End Users
1.3.1 EMEA Oligonucleotide Synthesis Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Academic
1.3.3 Pharmaceutical
1.3.4 Biotechnology
1.4 EMEA Oligonucleotide Synthesis Market by Region
1.4.1 EMEA Oligonucleotide Synthesis Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Oligonucleotide Synthesis (2013-2025)
1.5.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate (2013-2025)
1.5.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate (2013-2025)
2 EMEA OLIGONUCLEOTIDE SYNTHESIS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION
2.1 EMEA Oligonucleotide Synthesis Market Competition by Players/Manufacturers
2.1.1 EMEA Oligonucleotide Synthesis Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Oligonucleotide Synthesis Revenue and Share by Players (2013-2018)
2.1.3 EMEA Oligonucleotide Synthesis Sale Price by Players (2013-2018)
2.2 EMEA Oligonucleotide Synthesis (Volume and Value) by Type/Product Category
2.2.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Oligonucleotide Synthesis Sale Price by Type (2013-2018)
2.3 EMEA Oligonucleotide Synthesis (Volume) by Application
2.4 EMEA Oligonucleotide Synthesis (Volume and Value) by Region
2.4.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Oligonucleotide Synthesis Sales Price by Region (2013-2018)
3 EUROPE OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION
3.1 Europe Oligonucleotide Synthesis Sales and Value (2013-2018)
3.1.1 Europe Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
3.2 Europe Oligonucleotide Synthesis Sales and Market Share by Type
3.3 Europe Oligonucleotide Synthesis Sales and Market Share by Application
3.4 Europe Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Oligonucleotide Synthesis Sales Volume by Countries (2013-2018)
3.4.2 Europe Oligonucleotide Synthesis Revenue by Countries (2013-2018)
3.4.3 Germany Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.4 France Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.5 UK Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.6 Russia Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.7 Italy Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.8 Benelux Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4 MIDDLE EAST OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION
4.1 Middle East Oligonucleotide Synthesis Sales and Value (2013-2018)
4.1.1 Middle East Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
4.2 Middle East Oligonucleotide Synthesis Sales and Market Share by Type
4.3 Middle East Oligonucleotide Synthesis Sales and Market Share by Application
4.4 Middle East Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Oligonucleotide Synthesis Sales Volume by Countries (2013-2018)
4.4.2 Middle East Oligonucleotide Synthesis Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4.4.4 Israel Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4.4.5 UAE Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4.4.6 Iran Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5 AFRICA OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION
5.1 Africa Oligonucleotide Synthesis Sales and Value (2013-2018)
5.1.1 Africa Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
5.2 Africa Oligonucleotide Synthesis Sales and Market Share by Type
5.3 Africa Oligonucleotide Synthesis Sales and Market Share by Application
5.4 Africa Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Oligonucleotide Synthesis Sales Volume by Countries (2013-2018)
5.4.2 Africa Oligonucleotide Synthesis Revenue by Countries (2013-2018)
5.4.3 South Africa Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5.4.5 Egypt Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5.4.6 Algeria Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
6 EMEA OLIGONUCLEOTIDE SYNTHESIS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA
6.1 INTEGRATED DNA TECHNOLOGIES, INC.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 MERCK KGAA
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 MERCK KGAA Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 EUROFINS GENOMICS
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 EUROFINS GENOMICS Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 THERMO FISHER SCIENTIFIC INC.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 BIOAUTOMATION CORPORATION
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 AGILENT TECHNOLOGIES, INC.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 EUROGENTEC S.A.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 EUROGENTEC S.A. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 GENERAL ELECTRIC (GE) COMPANY
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 LGC BIOSEARCH TECHNOLOGIES, INC.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 NITTO DENKO AVECIA INC.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
7 OLIGONUCLEOTIDE SYNTHESIS MANUFACTURING COST ANALYSIS
7.1 Oligonucleotide Synthesis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oligonucleotide Synthesis
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Oligonucleotide Synthesis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2017
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA OLIGONUCLEOTIDE SYNTHESIS MARKET FORECAST (2018-2025)
11.1 EMEA Oligonucleotide Synthesis Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Oligonucleotide Synthesis Price and Trend Forecast (2018-2025)
11.2 EMEA Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Oligonucleotide Synthesis Sales Forecast by Type (2018-2025)
11.7 EMEA Oligonucleotide Synthesis Sales Forecast by Application (2018-2025)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 OLIGONUCLEOTIDE SYNTHESIS OVERVIEW
1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Classification of Oligonucleotide Synthesis
1.2.1 EMEA Oligonucleotide Synthesis Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Oligonucleotide Synthesis Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Primer
1.2.4 Probe
1.2.5 Reagent
1.3 EMEA Oligonucleotide Synthesis Market by Application/End Users
1.3.1 EMEA Oligonucleotide Synthesis Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Academic
1.3.3 Pharmaceutical
1.3.4 Biotechnology
1.4 EMEA Oligonucleotide Synthesis Market by Region
1.4.1 EMEA Oligonucleotide Synthesis Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Oligonucleotide Synthesis (2013-2025)
1.5.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate (2013-2025)
1.5.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate (2013-2025)
2 EMEA OLIGONUCLEOTIDE SYNTHESIS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION
2.1 EMEA Oligonucleotide Synthesis Market Competition by Players/Manufacturers
2.1.1 EMEA Oligonucleotide Synthesis Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Oligonucleotide Synthesis Revenue and Share by Players (2013-2018)
2.1.3 EMEA Oligonucleotide Synthesis Sale Price by Players (2013-2018)
2.2 EMEA Oligonucleotide Synthesis (Volume and Value) by Type/Product Category
2.2.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Oligonucleotide Synthesis Sale Price by Type (2013-2018)
2.3 EMEA Oligonucleotide Synthesis (Volume) by Application
2.4 EMEA Oligonucleotide Synthesis (Volume and Value) by Region
2.4.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Oligonucleotide Synthesis Sales Price by Region (2013-2018)
3 EUROPE OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION
3.1 Europe Oligonucleotide Synthesis Sales and Value (2013-2018)
3.1.1 Europe Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
3.2 Europe Oligonucleotide Synthesis Sales and Market Share by Type
3.3 Europe Oligonucleotide Synthesis Sales and Market Share by Application
3.4 Europe Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Oligonucleotide Synthesis Sales Volume by Countries (2013-2018)
3.4.2 Europe Oligonucleotide Synthesis Revenue by Countries (2013-2018)
3.4.3 Germany Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.4 France Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.5 UK Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.6 Russia Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.7 Italy Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
3.4.8 Benelux Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4 MIDDLE EAST OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION
4.1 Middle East Oligonucleotide Synthesis Sales and Value (2013-2018)
4.1.1 Middle East Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
4.2 Middle East Oligonucleotide Synthesis Sales and Market Share by Type
4.3 Middle East Oligonucleotide Synthesis Sales and Market Share by Application
4.4 Middle East Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Oligonucleotide Synthesis Sales Volume by Countries (2013-2018)
4.4.2 Middle East Oligonucleotide Synthesis Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4.4.4 Israel Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4.4.5 UAE Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
4.4.6 Iran Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5 AFRICA OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION
5.1 Africa Oligonucleotide Synthesis Sales and Value (2013-2018)
5.1.1 Africa Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
5.2 Africa Oligonucleotide Synthesis Sales and Market Share by Type
5.3 Africa Oligonucleotide Synthesis Sales and Market Share by Application
5.4 Africa Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Oligonucleotide Synthesis Sales Volume by Countries (2013-2018)
5.4.2 Africa Oligonucleotide Synthesis Revenue by Countries (2013-2018)
5.4.3 South Africa Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5.4.5 Egypt Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
5.4.6 Algeria Oligonucleotide Synthesis Sales and Growth Rate (2013-2018)
6 EMEA OLIGONUCLEOTIDE SYNTHESIS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA
6.1 INTEGRATED DNA TECHNOLOGIES, INC.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 MERCK KGAA
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 MERCK KGAA Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 EUROFINS GENOMICS
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 EUROFINS GENOMICS Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 THERMO FISHER SCIENTIFIC INC.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 BIOAUTOMATION CORPORATION
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 AGILENT TECHNOLOGIES, INC.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 EUROGENTEC S.A.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 EUROGENTEC S.A. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 GENERAL ELECTRIC (GE) COMPANY
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 LGC BIOSEARCH TECHNOLOGIES, INC.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 NITTO DENKO AVECIA INC.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
7 OLIGONUCLEOTIDE SYNTHESIS MANUFACTURING COST ANALYSIS
7.1 Oligonucleotide Synthesis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oligonucleotide Synthesis
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Oligonucleotide Synthesis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2017
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA OLIGONUCLEOTIDE SYNTHESIS MARKET FORECAST (2018-2025)
11.1 EMEA Oligonucleotide Synthesis Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Oligonucleotide Synthesis Price and Trend Forecast (2018-2025)
11.2 EMEA Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Oligonucleotide Synthesis Sales Forecast by Type (2018-2025)
11.7 EMEA Oligonucleotide Synthesis Sales Forecast by Application (2018-2025)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of Oligonucleotide Synthesis
Figure EMEA Oligonucleotide Synthesis Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Oligonucleotide Synthesis Sales Volume Market Share by Type (Product Category) in 2017
Figure Primer Product Picture
Figure Probe Product Picture
Figure Reagent Product Picture
Figure EMEA Oligonucleotide Synthesis Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Oligonucleotide Synthesis by Application in 2017
Figure Academic Examples
Table Key Downstream Customer in Academic
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Biotechnology Examples
Table Key Downstream Customer in Biotechnology
Figure EMEA Oligonucleotide Synthesis Market Size (Million USD) by Region (2013-2025)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2025)
Figure EMEA Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Oligonucleotide Synthesis Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Players (2013-2018)
Figure 2017 Oligonucleotide Synthesis Sales Share by Players
Figure 2017 Oligonucleotide Synthesis Sales Share by Players
Figure EMEA Oligonucleotide Synthesis Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) by Players (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue Share by Players (2013-2018)
Table 2017 EMEA Oligonucleotide Synthesis Revenue Share by Players
Table 2017 EMEA Oligonucleotide Synthesis Revenue Share by Players
Table EMEA Oligonucleotide Synthesis Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Type (2013-2018)
Figure Sales Market Share of Oligonucleotide Synthesis by Type (2013-2018)
Figure EMEA Oligonucleotide Synthesis Sales Market Share by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oligonucleotide Synthesis by Type in 2017
Table EMEA Oligonucleotide Synthesis Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Application (2013-2018)
Figure Sales Market Share of Oligonucleotide Synthesis by Application (2013-2018)
Figure EMEA Oligonucleotide Synthesis Sales Market Share by Application in 2017
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Region (2013-2018)
Figure Sales Market Share of Oligonucleotide Synthesis by Region (2013-2018)
Figure EMEA Oligonucleotide Synthesis Sales Market Share in 2017
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Oligonucleotide Synthesis by Region (2013-2018)
Figure EMEA Oligonucleotide Synthesis Revenue Market Share Regions in 2017
Table EMEA Oligonucleotide Synthesis Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
Table Europe Oligonucleotide Synthesis Sales (K Units) by Type (2013-2018)
Table Europe Oligonucleotide Synthesis Market Share by Type (2013-2018)
Figure Europe Oligonucleotide Synthesis Market Share by Type in 2017
Table Europe Oligonucleotide Synthesis Sales (K Units) by Application (2013-2018)
Table Europe Oligonucleotide Synthesis Market Share by Application (2013-2018)
Figure Europe Oligonucleotide Synthesis Market Share by Application in 2017
Table Europe Oligonucleotide Synthesis Sales (K Units) by Countries (2013-2018)
Table Europe Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Sales Market Share by Countries in 2017
Table Europe Oligonucleotide Synthesis Revenue (Million USD) by Countries (2013-2018)
Table Europe Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Revenue Market Share by Countries in 2017
Figure Germany Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure France Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure UK Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Oligonucleotide Synthesis Sales (K Units) by Type (2013-2018)
Table Middle East Oligonucleotide Synthesis Market Share by Type (2013-2018)
Figure Middle East Oligonucleotide Synthesis Market Share by Type (2013-2018)
Table Middle East Oligonucleotide Synthesis Sales (K Units) by Applications (2013-2018)
Table Middle East Oligonucleotide Synthesis Market Share by Applications (2013-2018)
Figure Middle East Oligonucleotide Synthesis Sales Market Share by Application in 2017
Table Middle East Oligonucleotide Synthesis Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Oligonucleotide Synthesis Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Oligonucleotide Synthesis Sales Volume Market Share by Countries in 2017
Table Middle East Oligonucleotide Synthesis Revenue (Million USD) by Countries (2013-2018)
Table Middle East Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Oligonucleotide Synthesis Sales (K Units) by Type (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Market Share by Type (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Type (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Type in 2017
Table Africa Oligonucleotide Synthesis Sales (K Units) by Application (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Market Share by Application (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Application (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Volume (K Units) by Countries (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Countries in 2017
Table Africa Oligonucleotide Synthesis Revenue (Million USD) by Countries (2013-2018)
Table Africa Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Revenue Market Share by Countries in 2017
Figure South Africa Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Table INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Basic Information List
Table INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table MERCK KGAA Oligonucleotide Synthesis Basic Information List
Table MERCK KGAA Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MERCK KGAA Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure MERCK KGAA Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure MERCK KGAA Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table EUROFINS GENOMICS Oligonucleotide Synthesis Basic Information List
Table EUROFINS GENOMICS Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure EUROFINS GENOMICS Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure EUROFINS GENOMICS Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure EUROFINS GENOMICS Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Basic Information List
Table THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Basic Information List
Table BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Basic Information List
Table AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table EUROGENTEC S.A. Oligonucleotide Synthesis Basic Information List
Table EUROGENTEC S.A. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure EUROGENTEC S.A. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure EUROGENTEC S.A. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure EUROGENTEC S.A. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Basic Information List
Table GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Basic Information List
Table LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Basic Information List
Table NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oligonucleotide Synthesis
Figure Manufacturing Process Analysis of Oligonucleotide Synthesis
Figure Oligonucleotide Synthesis Industrial Chain Analysis
Table Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2017
Table Major Buyers of Oligonucleotide Synthesis
Table Distributors/Traders List
Figure EMEA Oligonucleotide Synthesis Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Oligonucleotide Synthesis Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Region (2018-2025)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Oligonucleotide Synthesis Revenue Market Share Forecast by Region (2018-2025)
Table Europe Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2018-2025)
Table Europe Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2018-2025)
Table Africa Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Type (2018-2025)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Oligonucleotide Synthesis
Figure EMEA Oligonucleotide Synthesis Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Oligonucleotide Synthesis Sales Volume Market Share by Type (Product Category) in 2017
Figure Primer Product Picture
Figure Probe Product Picture
Figure Reagent Product Picture
Figure EMEA Oligonucleotide Synthesis Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Oligonucleotide Synthesis by Application in 2017
Figure Academic Examples
Table Key Downstream Customer in Academic
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Biotechnology Examples
Table Key Downstream Customer in Biotechnology
Figure EMEA Oligonucleotide Synthesis Market Size (Million USD) by Region (2013-2025)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oligonucleotide Synthesis Sales Volume and Growth Rate (2013-2025)
Figure EMEA Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Oligonucleotide Synthesis Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Players (2013-2018)
Figure 2017 Oligonucleotide Synthesis Sales Share by Players
Figure 2017 Oligonucleotide Synthesis Sales Share by Players
Figure EMEA Oligonucleotide Synthesis Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) by Players (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue Share by Players (2013-2018)
Table 2017 EMEA Oligonucleotide Synthesis Revenue Share by Players
Table 2017 EMEA Oligonucleotide Synthesis Revenue Share by Players
Table EMEA Oligonucleotide Synthesis Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Type (2013-2018)
Figure Sales Market Share of Oligonucleotide Synthesis by Type (2013-2018)
Figure EMEA Oligonucleotide Synthesis Sales Market Share by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oligonucleotide Synthesis by Type in 2017
Table EMEA Oligonucleotide Synthesis Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Application (2013-2018)
Figure Sales Market Share of Oligonucleotide Synthesis by Application (2013-2018)
Figure EMEA Oligonucleotide Synthesis Sales Market Share by Application in 2017
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Oligonucleotide Synthesis Sales Share by Region (2013-2018)
Figure Sales Market Share of Oligonucleotide Synthesis by Region (2013-2018)
Figure EMEA Oligonucleotide Synthesis Sales Market Share in 2017
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Oligonucleotide Synthesis Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Oligonucleotide Synthesis by Region (2013-2018)
Figure EMEA Oligonucleotide Synthesis Revenue Market Share Regions in 2017
Table EMEA Oligonucleotide Synthesis Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)
Table Europe Oligonucleotide Synthesis Sales (K Units) by Type (2013-2018)
Table Europe Oligonucleotide Synthesis Market Share by Type (2013-2018)
Figure Europe Oligonucleotide Synthesis Market Share by Type in 2017
Table Europe Oligonucleotide Synthesis Sales (K Units) by Application (2013-2018)
Table Europe Oligonucleotide Synthesis Market Share by Application (2013-2018)
Figure Europe Oligonucleotide Synthesis Market Share by Application in 2017
Table Europe Oligonucleotide Synthesis Sales (K Units) by Countries (2013-2018)
Table Europe Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Sales Market Share by Countries in 2017
Table Europe Oligonucleotide Synthesis Revenue (Million USD) by Countries (2013-2018)
Table Europe Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Europe Oligonucleotide Synthesis Revenue Market Share by Countries in 2017
Figure Germany Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure France Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure UK Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Oligonucleotide Synthesis Sales (K Units) by Type (2013-2018)
Table Middle East Oligonucleotide Synthesis Market Share by Type (2013-2018)
Figure Middle East Oligonucleotide Synthesis Market Share by Type (2013-2018)
Table Middle East Oligonucleotide Synthesis Sales (K Units) by Applications (2013-2018)
Table Middle East Oligonucleotide Synthesis Market Share by Applications (2013-2018)
Figure Middle East Oligonucleotide Synthesis Sales Market Share by Application in 2017
Table Middle East Oligonucleotide Synthesis Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Oligonucleotide Synthesis Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Oligonucleotide Synthesis Sales Volume Market Share by Countries in 2017
Table Middle East Oligonucleotide Synthesis Revenue (Million USD) by Countries (2013-2018)
Table Middle East Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Oligonucleotide Synthesis Sales (K Units) by Type (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Market Share by Type (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Type (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Type in 2017
Table Africa Oligonucleotide Synthesis Sales (K Units) by Application (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Market Share by Application (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Application (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Volume (K Units) by Countries (2013-2018)
Table Africa Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Countries in 2017
Table Africa Oligonucleotide Synthesis Revenue (Million USD) by Countries (2013-2018)
Table Africa Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Revenue Market Share by Countries (2013-2018)
Figure Africa Oligonucleotide Synthesis Revenue Market Share by Countries in 2017
Figure South Africa Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Table INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Basic Information List
Table INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table MERCK KGAA Oligonucleotide Synthesis Basic Information List
Table MERCK KGAA Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MERCK KGAA Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure MERCK KGAA Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure MERCK KGAA Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table EUROFINS GENOMICS Oligonucleotide Synthesis Basic Information List
Table EUROFINS GENOMICS Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure EUROFINS GENOMICS Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure EUROFINS GENOMICS Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure EUROFINS GENOMICS Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Basic Information List
Table THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Basic Information List
Table BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Basic Information List
Table AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table EUROGENTEC S.A. Oligonucleotide Synthesis Basic Information List
Table EUROGENTEC S.A. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure EUROGENTEC S.A. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure EUROGENTEC S.A. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure EUROGENTEC S.A. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Basic Information List
Table GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Basic Information List
Table LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Basic Information List
Table NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2013-2018)
Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales Market Share in EMEA (2013-2018)
Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oligonucleotide Synthesis
Figure Manufacturing Process Analysis of Oligonucleotide Synthesis
Figure Oligonucleotide Synthesis Industrial Chain Analysis
Table Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2017
Table Major Buyers of Oligonucleotide Synthesis
Table Distributors/Traders List
Figure EMEA Oligonucleotide Synthesis Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Oligonucleotide Synthesis Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Region (2018-2025)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Oligonucleotide Synthesis Revenue Market Share Forecast by Region (2018-2025)
Table Europe Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2018-2025)
Table Europe Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2018-2025)
Table Africa Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Type (2018-2025)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources